SCOLR Pharma, Inc. Engaged By Leading Consumer Products Company To Co-Develop Novel Application Of Its CDT(R) Delivery Platform

BELLEVUE, Wash.--(BUSINESS WIRE)--Sept. 14, 2006--SCOLR Pharma, Inc. (Amex: DDD) today announced a research agreement with a global consumer products company to co-develop a novel application of its CDT(R) drug delivery technology.

MORE ON THIS TOPIC